EMILY LOWELL: Open Payments
NPI 1841924982 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,536 in 345 payments from 35 companies in 2025. Trend: 2023 $17 · 2024 $3,321 · 2025 $4,536
Food & beverage: $4,464Education: $73
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 62 | $606 |
| Lundbeck LLC | 34 | $376 |
| Teva Pharmaceuticals USA, Inc. | 32 | $355 |
| Neurocrine BioSciences, Inc. | 25 | $329 |
| PFIZER INC. | 28 | $329 |
| Novartis Pharmaceuticals Corporation | 28 | $291 |
| UCB, Inc. | 23 | $248 |
| Biogen, Inc. | 18 | $209 |
| Janssen Biotech, Inc. | 5 | $156 |
| ARGENX US, INC. | 10 | $141 |
Products named: VYEPTI, INGREZZA, KESIMPTA, AUSTEDO XR, BOTOX, NURTEC ODT, UBRELVY, QULIPTA.
Industry payments across NE — which companies pay providers there.
